Form 4: Charles River Labs Exec Sells Shares

Glenn Coleman, EVP & Chief Financial Officer of Charles River Laboratories International, Inc., reported a transaction involving the disposition of 21,112 shares of common stock.

Summary

• Glenn Coleman, Executive Vice President and Chief Financial Officer of Charles River Laboratories International, Inc., reported a disposition of 21,112 shares of common stock on May 1, 2026.
• The transaction was executed at a price of $165.78 per share.
• Following this transaction, Coleman beneficially owns 21,112 shares of common stock directly.
• The reported shares were unvested restricted stock units that vest annually on May 1, 2027, May 1, 2028, May 1, 2029, and May 1, 2030.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative sentiment due to the disposition of a significant number of shares by a CFO, although the context of vesting schedules may mitigate concerns.

Negatives

• Executive officer disposed of a significant number of shares (21,112).

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. While this filing indicates a disposition of shares by a key executive, it is important to consider the context of the transaction, such as whether it was part of a pre-arranged trading plan (Rule 10b5-1) or related to vesting schedules, which are often standard for executive compensation.

Stakeholder Impact

• Shareholders may view the disposition of shares by the CFO with caution, potentially impacting short-term investor sentiment.
• Employees may observe this transaction as part of standard executive compensation and vesting practices.

Key Dates

Keywords

Form 4, Insider Trading, Stock Disposition, Charles River Laboratories, Glenn Coleman, CFO, Restricted Stock Units